DNA-damaging activity and mutagenicity of 16 newly synthesized thiazolo[5,4-a]acridine derivatives with high photo-inducible cytotoxicity

Denny, 2002, Acridine derivatives as chemotherapeutic agents, Curr. Med. Chem., 9, 1655, 10.2174/0929867023369277 Wainwright, 2001, Acridine-a neglected antibacterial chromophore, J. Antimicrob. Chemother., 47, 1, 10.1093/jac/47.1.1 Belmont, 2007, Acridine and acridone derivatives, anticancer properties and synthetic methods: where are we now?, Anticancer Agents Med. Chem., 7, 139, 10.2174/187152007780058669 Bongui, 2005, Synthesis and cytotoxic activity of acronycine analogues in the benzo[c]pyrano[3,2-h]acridin-7-one and naphtho[1,2-b][1,7] and [1,10]-phenanthrolin-7(14H)-one series, Chem. Pharm. Bull. (Tokyo), 53, 1540, 10.1248/cpb.53.1540 Seguin, 2005, Structure activity relationships and mechanism of action of antitumor benzo[b]acronycine antitumor agents, Ann. Pharm. Fr., 63, 44, 10.1016/S0003-4509(05)82250-3 Burres, 1989, Antitumor activity and nucleic acid binding properties of dercitin, a new acridine alkaloid isolated from a marine Dercitus species sponge, Cancer Res., 49, 5267 Taraporewala, 1992, HIV-1 neutralization and tumor cell proliferation inhibition in vitro by simplified analogues of pyrido[4,3,2-mn]thiazolo[5,4-b]acridine marine alkaloids, J. Med. Chem., 35, 2744, 10.1021/jm00093a005 Rajendran, 2006, BU Unprecedented dual binding behaviour of acridine group of dye: a combined experimental and theoretical investigation for the development of anticancer chemotherapeutic agents, Biochim. Biophys. Acta, 1760, 1794, 10.1016/j.bbagen.2006.08.011 Denny, 2003, Dual topoisomerase I/II inhibitors in cancer therapy, Curr. Top Med. Chem., 3, 339, 10.2174/1568026033452555 L.R. Ferguson, W.A. Denny, Genotoxicity of non-covalent interactions: DNA intercalators, Mutat. Res. (2007) 6 (Epub ahead of print). Ferguson, 1991, The genetic toxicology of acridines, Mutat. Res., 258, 123, 10.1016/0165-1110(91)90006-H Cancel, 2006, A one-year neonatal mouse carcinogenesis study of quinacrine dihydrochloride, Int. J. Toxicol., 25, 109, 10.1080/10915810600605773 Brown, 1993, A proflavin-induced frameshift hotspot in the thymidylate synthase gene of bacteriophage T4, Mutation Res., 286, 189, 10.1016/0027-5107(93)90183-G Narayanan, 2005, Comparative analysis of mutagenic potency of 1-nitro-acridine derivatives, Life Sci., 77, 2312, 10.1016/j.lfs.2005.03.020 Hoffmann, 2003, Frameshift mutations induced by three classes of acridines in the lacZ reversion assay in Escherichia coli: potency of responses and relationship to slipped mispairing models, Environ. Mol. Mutagen., 42, 111, 10.1002/em.10182 Ferguson, 2000, The mutagenic spectrum of acridine-linked aniline nitrogen mustards in AS52 cells: implications of DNA targeting with high selectivity for adenine or guanine bases, Mutat. Res., 469, 115, 10.1016/S1383-5718(00)00067-X Brown, 1980, Acridine structure correlated with mutagenic activity in Salmonella, Mutat. Res., 72, 373, 10.1016/0027-5107(80)90112-8 Tomosaka, 1997, The effects of substituents introduced into 9-aminoacridine on frameshift mutagenicity and DNA binding affinity, Biosci. Biotechnol. Biochem., 61, 1121, 10.1271/bbb.61.1121 Ferguson, 1983, Frameshift mutagenesis by 9-aminoacridine, ICR191, AMSA and related experimental antitumour acridines in recA+ and recA1 strains of Salmonella typhimurium, Mutat. Res., 116, 289, 10.1016/0165-1218(83)90066-6 Ferguson, 1990, Frameshift mutagenesis by acridines and other reversibly-binding DNA ligands, Mutagenesis, 5, 529, 10.1093/mutage/5.6.529 De Marini, 1998, Spectra of spontaneous frameshift mutations at the hisD3052 allele of Salmonella typhimurium in four repair backgrounds, Genetics, 149, 17, 10.1093/genetics/149.1.17 Chen, 2000, Cytotoxicity and mutagenicity of frameshift-inducing agent ICR191 in mismatch repair-deficient colon cancer cells, J. Natl. Cancer Inst., 92, 440, 10.1093/jnci/92.6.480 Tanaka, 1996, Diverse mutagenicity of methylbenz(c)acridines in the direct Ames’ Salmonella mutagenicity test, Anticancer Res., 16, 2837 Baguley, 2003, Mechanisms of action of DNA intercalating acridine-based drugs: how important are contributions from electron transfer and oxidative stress?, Curr. Med. Chem., 10, 2643, 10.2174/0929867033456332 Yang, 2006, Isoquino[4,5-bc]acridines: design, synthesis and evaluation of DNA binding, anti-tumor and DNA photo-damaging ability, J. Photochem. Photobiol. B, 84, 221, 10.1016/j.jphotobiol.2006.03.005 Burres, 1992, A colorimetric microassay for the detection of agents that interact with DNA, J. Nat. Prod., 55, 1582, 10.1021/np50089a004 Maron, 1983, Revised methods for the Salmonella mutagenicity test, Mutat. Res., 113, 173, 10.1016/0165-1161(83)90010-9 Decome, 2005, Evaluation of photolyase repair activity in human keratinocytes after a single dose ultraviolet B irradiation using the comet assay, J. Photochem. Photobiol. B, 79, 101, 10.1016/j.jphotobiol.2004.11.022 Kirsch-Volders, 2003, Report from the in vitro micronucleus assay working group, Mutat. Res., 540, 153, 10.1016/j.mrgentox.2003.07.005 Robin, 2002, Synthesis of two novel classes of tetracycles bearing tetrahydro ring system from benzothiazole: 7,8,9,10-tetrahydro[1,3]thiazolo[5,4-a]acridine and 1,2,3,4-tetrahydro-12H-[1,3]benzothiazole [2,3-b] quinazolin-12-one, J. Heterocycl. Chem., 39, 295, 10.1002/jhet.5570390208 De Meo, 1996, Optimization of the Salmonella/mammalian microsome assay for urine mutagenesis by experimental designs, Mutat. Res., 340, 51, 10.1016/S0165-1110(96)90039-1 Davoren, 2007, In vitro toxicity evaluation of single walled carbon nanotubes on human A549 lung cells, Toxicol. In Vitro, 21, 438, 10.1016/j.tiv.2006.10.007 D’Errico, 2003, Apoptosis and efficient repair of DNA damage protect human keratinocytes against UVB, Cell Death Differ., 10, 754, 10.1038/sj.cdd.4401224 Phillipson, 2002, UV-A induces persistent genomic instability in human keratinocytes through an oxidative stress mechanism, Free Radic. Biol. Med., 32, 474, 10.1016/S0891-5849(01)00829-2 Curren, 2006, Development of a method for assessing micronucleus induction in a 3D human skin model (EpiDerm), Mutat. Res., 607, 192, 10.1016/j.mrgentox.2006.04.016 Fenech, 2000, The in vitro micronucleus technique, Mutat. Res., 455, 81, 10.1016/S0027-5107(00)00065-8 Anderson, 1989, Statistical analysis of in vivo cytogenetic assays, 1989, 184 Rogers, 1994, Application of genetic function approximation to quantitative structure activity relationships and quantitative structure property relationships, J. Chem. Inf. Comp. Sci., 34, 854, 10.1021/ci00020a020 2000, 667 Levin, 1986, Classifying mutagens as to their specificity in causing the six possible transitions and transversions: a simple analysis using the Salmonella mutagenicity assay, Environ. Mutagen., 8, 9, 10.1002/em.2860080103 Aslanoglu, 2004, Voltametric studies of the interaction of quinacrine with DNA, Anal. Bioanal. Chem., 380, 658, 10.1007/s00216-004-2797-5 Clarke, 2001, Re-eveluation of the mutagenic potential of quinacrine dihydrochloride dehydrate, Mutat. Res., 494, 41, 10.1016/S1383-5718(01)00178-4 Turesky, 2002, Heterocyclic aromatic amine metabolism, DNA adduct formation, mutagenesis, and carcinogenesis, Drug Metab. Rev., 34, 625, 10.1081/DMR-120005665 Xue, 2005, Metabolic activation of polycyclic and heterocyclic aromatic hydrocarbons and DNA damage: a review, Toxicol. Appl. Pharmacol., 206, 73, 10.1016/j.taap.2004.11.006 Firth, 1981, Azido analogs of acridine: photoaffinity probes for frameshift mutagenesis in Salmonella typhimurium, Mutat. Res., 81, 295, 10.1016/0027-5107(81)90118-4 Snyder, 2002, Putative identification of functional interactions between DNA intercalating agents and topoisomerase II using the V79 in vitro micronucleus assay, Mutat. Res., 503, 21, 10.1016/S0027-5107(02)00028-3 Bohne, 2005, Studies on the mechanism of the photo-induced DNA damage in the presence of acridizinium salts-involvement of singlet oxygen and an unusual source for hydroxyl radicals, J. Am. Chem. Soc., 127, 76, 10.1021/ja046189m Boos, 2000, Genotoxicity of several clinically used topoisomerase II inhibitors, Toxicol. Lett., 116, 7, 10.1016/S0378-4274(00)00192-2 Ribas, 1996, Sister-chromatid exchanges (SCE) induction by inhibitors of DNA topoisomerases in cultured human lymphocytes, Mutat. Res., 368, 205, 10.1016/S0165-1218(96)90062-2 Bomhard, 2003, High-dose clastogenic activity of aniline in the rat bone marrow and its relationship to the carcinogenicity in the spleen of rats, Arch. Toxicol., 77, 291, 10.1007/s00204-003-0443-1 Huang, 2006, Quinacrine is mainly metabolized to mono-desethyl quinacrine by CYP3A4/5 and its brain accumulation is limited by P-glycoprotein, Drug Metab. Dispos., 34, 1136, 10.1124/dmd.105.008664 Gorlewska, 2001, Products of metabolic activation of the antitumor drug ledakrin (nitracrine) in vitro, Chem. Res. Toxicol., 14, 1, 10.1021/tx000081c Mazerska, 2003, Similarity between enzymatic and electrochemical oxidation of 2-hydroxyacridinone, the reference compound of antitumor midazoacridinones, Acta Biochim. Pol., 50, 515, 10.18388/abp.2003_3704 Pfeiffer, 2000, Mechanisms of DNA double-strand break repair and their potential to induce chromosomal aberrations, Mutagenesis, 15, 289, 10.1093/mutage/15.4.289 Van Den Bosch, 2002, DNA double-strand break repair by homologous recombination, Biol. Chem., 383, 873, 10.1515/BC.2002.095 Blasiak, 2003, Free radical scavengers can differentially modulate the genotoxicity of amsacrine in normal and cancer cells, Mutat. Res., 535, 25, 10.1016/S1383-5718(02)00289-9 Topcu, 2001, DNA topoisomerases as target for anticancer drugs, J. Clin. Pharm. Ther., 26, 405, 10.1046/j.1365-2710.2001.00368.x